ArticleCardiovascular diabetology2025

Plasma metabolomics disentangles T2DM- and CAD-specific dysmetabolism and identifies potential biomarkers for CAD risk escalation in diabetic patients.

Ting Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.